Cargando…
Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma
BACKGROUND: Deletion of 1p is associated with poor prognosis in neuroblastoma, however selected 1p-intact patients still experience poor outcomes. Since mutations of 1p genes may mimic the deleterious effects of chromosomal loss, we studied the incidence, spectrum and effects of mutational variants...
Autores principales: | Kuick, Chik Hong, Tan, Jia Ying, Jasmine, Deborah, Sumanty, Tohari, Ng, Alvin Y. J., Venkatesh, Byrrappa, Chen, Huiyi, Loh, Eva, Jain, Sudhanshi, Seow, Wan Yi, Ng, Eileen H. Q., Lian, Derrick W. Q., Soh, Shui Yen, Chang, Kenneth T. E., Chen, Zhi Xiong, Loh, Amos H. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245282/ https://www.ncbi.nlm.nih.gov/pubmed/35768791 http://dx.doi.org/10.1186/s12885-022-09800-0 |
Ejemplares similares
-
Platform Comparison for Evaluation of ALK Protein Immunohistochemical Expression, Genomic Copy Number and Hotspot Mutation Status in Neuroblastomas
por: Yan, Benedict, et al.
Publicado: (2014) -
Primary paediatric epidural sarcomas: molecular exploration of three cases
por: Low, Sharon Y. Y., et al.
Publicado: (2019) -
Neuroblastoma patient‐derived cultures are enriched for a mesenchymal gene signature and reflect individual drug response
por: Hee, Esther, et al.
Publicado: (2020) -
XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis
por: Choo, Zhang'e, et al.
Publicado: (2016) -
Whole-Exome Sequencing to Identify Potential Genetic Risk in Substance Use Disorders: A Pilot Feasibility Study
por: AshaRani, P. V., et al.
Publicado: (2021)